Time-Dependent Serum Brain-Derived Neurotrophic Factor Decline During Methamphetamine Withdrawal

Area of Science:

• Neuroscience
• Psychiatry
• Addiction Medicine

Background:

• Methamphetamine (METH) is a neurotoxic psychostimulant with widespread abuse.
• Research on brain-derived neurotrophic factor (BDNF) in METH addiction is limited and inconsistent.

Purpose of the Study:

• Compare serum BDNF levels in METH addicts versus healthy controls during early withdrawal.
• Investigate changes in serum BDNF levels during the first month of METH abstinence.

Main Methods:

• Recruited 179 METH addicts and 90 healthy controls.
• Measured serum BDNF levels at baseline for both groups.
• Re-measured serum BDNF in METH addicts after 1 month of abstinence.

Main Results:

• METH addicts exhibited significantly higher baseline serum BDNF levels than controls.
• Serum BDNF levels in METH addicts decreased significantly after 1 month of abstinence.
• Post-abstinence BDNF levels in METH addicts did not differ from control levels.

Conclusions:

• Elevated serum BDNF during early METH withdrawal may indicate a protective response to neurotoxicity.
• Serum BDNF levels decrease over the first month of abstinence.
• Findings may inform therapeutic strategies for METH addiction and withdrawal.